Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL BIOMATERIALS FOR TISSUE ENGINEERING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL BIOMATERIALS FOR TISSUE ENGINEERING MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 EPIDEMIOLOGY MODELING
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL BIOMATERIALS FOR TISSUE ENGINEERING MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER'S 5 FORCES
4.2 PESTEL ANALYSIS
5 EPIDEMIOLOGY
5.1 INCIDENCE OF ALL BY GENDER
5.2 TREATMENT RATE
5.3 MORTALITY RATE
5.4 DRUG ADHERENCE AND THERAPY SWITCH MODEL
5.5 PATEINT TREATMENT SUCCESS RATES
6 INDUSTRY INSIGHTS
6.1 PATENT ANALYSIS
6.2 DRUG TREATMENT RATE BY MATURED MARKETS
6.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES
6.4 PATIENT FLOW DIAGRAM
6.5 KEY PRICING STRATEGIES
6.6 KEY PATIENT ENROLLMENT STRATEGIES
6.7 INTERVIEWS WITH HEMATOLOGISTS
6.8 INTERVIEWS WITH ONCOLOGISTS
6.9 INTERVIEWS WITH CANCER ORGANIZATIONS
6.1 OTHER KOL SNAPSHOTS
7 PIPELINE ANALYSIS
7.1 CLINICAL TRIALS AND PHASE ANALYSIS
7.2 PHASE III CANDIDATES
7.3 PHASE II CANDIDATES
7.4 PHASE I CANDIDATES
7.5 OTHERS (PRE-CLINICAL AND RESEARCH)
8 GLOBAL BIOMATERIALS FOR TISSUE ENGINEERING MARKET, BY TYPE
8.1 OVERVIEW
8.2 METALLIC BIOMATERIALS
8.2.1 STAINLESS STEEL
8.2.2 TITANIUM & TITANIUM ALLOYS
8.2.3 OBALT-CHROME ALLOYS
8.2.4 GOLD
8.2.5 SILVER
8.2.6 MAGNESIUM
8.2.7 OTHERS
8.3 POLYMERIC BIOMATERIALS
8.3.1 POLYMETHYLMETHACRYLATE (PMMA)
8.3.2 POLYETHLENE
8.3.3 POLYESTER
8.3.4 NYLON
8.3.5 POLYVINCYCHLORIDE
8.3.6 SILICONE RUBBER
8.3.7 POLYETHERETHERKETONE
8.3.8 OTHERS
8.4 CERAMIC BIOMATERIALS
8.4.1 CALCIUM PHOSPHATE
8.4.2 ZIRCONIA
8.4.3 ALUMINUM OXIDE
8.4.4 CALCIUM SULFATE
8.4.5 CARBON
8.4.6 GLASS
8.4.7 OTHERS
8.5 NATURAL BIOMATERIALS
8.5.1 HYALURONIC ACID
8.5.2 COLLAGEN
8.5.3 GELATIN
8.5.4 FIBRIN
8.5.5 CELLULOSE
8.5.6 CHITIN
8.5.7 ALGINATE
8.5.8 SILK
8.5.9 OTHERS
9 GLOBAL BIOMATERIALS FOR TISSUE ENGINEERING MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 STEM CELLS
9.3 CELLS AND BIOMATERIALS
9.4 BIOMATERIALS
9.5 OTHERS
10 GLOBAL BIOMATERIALS FOR TISSUE ENGINEERING MARKET, BY COMPONENT
10.1 OVERVIEW
10.2 SCAFFOLD
10.3 GROWTH FACTORS
10.4 MATRIX
10.5 CELLS
11 GLOBAL BIOMATERIALS FOR TISSUE ENGINEERING MARKET, BY SOURCE OF CELL
11.1 OVERVIEW
11.2 AUTOLOGUS
11.2.1 MATURE
11.2.2 ADULT STEM CELLS
11.2.3 EMBRYONIC STEM CELLS
11.2.4 TITOPOTENT STEM CELLS
11.3 ALLOGENIC
11.3.1 MATURE
11.3.2 ADULT STEM CELLS
11.3.3 EMBRYONIC STEM CELLS
11.3.4 TITOPOTENT STEM CELLS
11.4 XENOGENIC
11.4.1 MATURE
11.4.2 ADULT STEM CELLS
11.4.3 EMBRYONIC STEM CELLS
11.4.4 TITOPOTENT STEM CELLS
12 GLOBAL BIOMATERIALS FOR TISSUE ENGINEERING MARKET, BY DEGRADABILITY
12.1 OVERVIEW
12.2 BIODEGRADABLE
12.3 NON-BIODEGRADABLE
13 GLOBAL BIOMATERIALS FOR TISSUE ENGINEERING MARKET, BY APPLICATION
13.1 OVERVIEW
13.2 CARDIOVASCULAR
13.2.1 CATHETERS
13.2.2 STENTS
13.2.3 IMPLANTABLE CARDIAC DEFIBRILLATORS
13.2.4 PACEMAKERS
13.2.5 SENSORS
13.2.6 HEART VALVES
13.2.7 VASCULAR GRAFT
13.2.8 GUIDEWIRES
13.2.9 OTHER PRODUCTS
13.3 ORTHOPEDIC
13.3.1 KNEE REPLACEMENT
13.3.2 HIP REPLACEMENT
13.3.3 SHOULDER REPLACEMENT
13.3.4 OTHERS
13.4 VISCOSUPPLEMENTATION
13.4.1 BIORESORBABLE TISSUE FIXATION
13.4.1.1. SUTURE ANCHORS
13.4.1.2. INTERFERENCE SCREWS
13.4.1.3. MENISCAL REPAIR TACKS
13.4.1.4. MESHES
13.4.2 SPINE
13.4.2.1. SPINAL FUSION
13.4.2.2. MINIMAL INVASIVE FUSION
13.4.2.3. MOTION PRESERVATION & DYNAMIC STABILIZATION
13.4.2.3.1. PEDICLE-BASED ROD SYSTEMS
13.4.2.3.2. ARTIFICIAL DISCS
13.4.2.3.3. INTERSPINOUS SPACERS
13.4.3 FRACTURE FIXATION DEVICES
13.4.3.1. BONE PLATES
13.4.3.2. SCREWS
13.4.3.3. PINS
13.4.3.4. RODS
13.4.3.5. WIRES
13.4.4 SYNTHETICS BONE GRAFTS
13.5 OPHTHALMOLOGY
13.5.1 CONTACT LENSES
13.5.2 INTRAOCULAR LENSES
13.5.3 FUNCTIONAL REPLACEMENT OF OCULAR TISSUES
13.5.4 SYNTHETIC CORNEAS
13.5.5 OTHER OPHTHALMOLOGY APPLICATIONS
13.6 DENTAL
13.6.1 DENTAL IMPLANTS
13.6.2 DENTAL BONE GRAFTS & SUBSTITUTES
13.6.3 DENTAL MEMBRANES
13.6.4 TISSUE REGENERATION MATERIALS
13.7 PLASTIC SURGERY
13.7.1 SOFT-TISSUE FILLERS
13.7.2 CRANIOFACIAL SURGERY
13.7.3 OTHERS
13.8 WOUND HEALING
13.8.1 WOUND CLOSURE DEVICES
13.8.1.1. SUTURES
13.8.1.2. STAPLERS
13.8.2 SURGICAL HEMOSTATS
13.8.3 INTERNAL TISSUE SEALANTS
13.8.4 ADHESION BARRIERS
13.8.5 HERNIA MESHES
13.8.6 OTHERS
13.9 TISSUE ENGINEERING
13.9.1 SCAFFOLDS FOR REGENERATIVE MEDICINE
13.9.2 NANOMATERIALS FOR BIOSENSING
13.9.3 TAILORING OF INORGANIC NANOPARTICLES
13.1 NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS
13.10.1 SHUNTING SYSTEMS
13.10.2 CORTICAL NEURAL PROSTHETICS
13.10.3 HYDROGEL SCAFFOLDS FOR CNS REPAIR
13.10.4 NEURAL STEM CELL ENCAPSULATION
13.11 OTHER APPLICATIONS
13.11.1 DRUG DELIVERY SYSTEMS
13.11.2 GASTROINTESTINAL APPLICATIONS
13.11.3 BARIATRIC SURGERY
13.11.4 URINARY APPLICATIONS
14 GLOBAL BIOMATERIALS FOR TISSUE ENGINEERING MARKET, BY END USER
14.1 OVERVIEW
14.2 PHARMACEUTICAL INDUSTRIES
14.3 ACADEMIC/ RESEARCH INSTITUTE
14.4 HOSPITALS
14.5 OTHERS
15 GLOBAL BIOMATERIALS FOR TISSUE ENGINEERING MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: GLOBAL
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3 COMPANY SHARE ANALYSIS: EUROPE
15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
15.5 MERGERS & ACQUISITIONS
15.6 NEW PRODUCT DEVELOPMENT & APPROVALS
15.7 EXPANSIONS
15.8 REGULATORY CHANGES
15.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
16 GLOBAL BIOMATERIALS FOR TISSUE ENGINEERING MARKET, BY GEOGRAPHY
16.1 GLOBAL BIOMATERIALS FOR TISSUE ENGINEERING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
16.2 NORTH AMERICA
16.2.1 U.S.
16.2.2 CANADA
16.2.3 MEXICO
16.3 EUROPE
16.3.1 GERMANY
16.3.2 FRANCE
16.3.3 U.K.
16.3.4 HUNGARY
16.3.5 LITHUANIA
16.3.6 AUSTRIA
16.3.7 IRELAND
16.3.8 NORWAY
16.3.9 POLAND
16.3.10 ITALY
16.3.11 SPAIN
16.3.12 RUSSIA
16.3.13 TURKEY
16.3.14 NETHERLANDS
16.3.15 SWITZERLAND
16.3.16 REST OF EUROPE
16.4 ASIA-PACIFIC
16.4.1 JAPAN
16.4.2 CHINA
16.4.3 SOUTH KOREA
16.4.4 INDIA
16.4.5 AUSTRALIA
16.4.6 SINGAPORE
16.4.7 THAILAND
16.4.8 MALAYSIA
16.4.9 INDONESIA
16.4.10 PHILIPPINES
16.4.11 VIETNAM
16.4.12 REST OF ASIA-PACIFIC
16.5 SOUTH AMERICA
16.5.1 BRAZIL
16.5.2 ARGENTINA
16.5.3 PERU
16.5.4 REST OF SOUTH AMERICA
16.6 MIDDLE EAST AND AFRICA
16.6.1 SOUTH AFRICA
16.6.2 GLOBAL
16.6.3 UAE
16.6.4 EGYPT
16.6.5 KUWAIT
16.6.6 ISRAEL
16.6.7 REST OF MIDDLE EAST AND AFRICA
16.7 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
17 GLOBAL BIOMATERIALS FOR TISSUE ENGINEERING MARKET, SWOT AND DBMR ANALYSIS
18 GLOBAL BIOMATERIALS FOR TISSUE ENGINEERING MARKET, COMPANY PROFILE
18.1 ORGANOGENESIS
18.1.1 COMPANY OVERVIEW
18.1.2 REVENUE ANALYSIS
18.1.3 GEOGRAPHIC PRESENCE
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 MIMEDX
18.2.1 COMPANY OVERVIEW
18.2.2 REVENUE ANALYSIS
18.2.3 GEOGRAPHIC PRESENCE
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 SMITH & NEPHEW
18.3.1 COMPANY OVERVIEW
18.3.2 REVENUE ANALYSIS
18.3.3 GEOGRAPHIC PRESENCE
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.4 SHIRE REGENERATIVE MEDICINE
18.4.1 COMPANY OVERVIEW
18.4.2 REVENUE ANALYSIS
18.4.3 GEOGRAPHIC PRESENCE
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENTS
18.5 COOK BIOTECH
18.5.1 COMPANY OVERVIEW
18.5.2 REVENUE ANALYSIS
18.5.3 GEOGRAPHIC PRESENCE
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 BIOMIMETIC SOLUTIONS
18.6.1 COMPANY OVERVIEW
18.6.2 REVENUE ANALYSIS
18.6.3 GEOGRAPHIC PRESENCE
18.6.4 PRODUCT PORTFOLIO
18.6.5 RECENT DEVELOPMENTS
18.7 ZIMMER BIOTECH
18.7.1 COMPANY OVERVIEW
18.7.2 REVENUE ANALYSIS
18.7.3 GEOGRAPHIC PRESENCE
18.7.4 PRODUCT PORTFOLIO
18.7.5 RECENT DEVELOPMENTS
18.8 ACELITY
18.8.1 COMPANY OVERVIEW
18.8.2 REVENUE ANALYSIS
18.8.3 GEOGRAPHIC PRESENCE
18.8.4 PRODUCT PORTFOLIO
18.8.5 RECENT DEVELOPMENTS
18.9 RTI SURGICAL
18.9.1 COMPANY OVERVIEW
18.9.2 REVENUE ANALYSIS
18.9.3 GEOGRAPHIC PRESENCE
18.9.4 PRODUCT PORTFOLIO
18.9.5 RECENT DEVELOPMENTS
18.1 TISSUE REGENIX GROUP
18.10.1 COMPANY OVERVIEW
18.10.2 REVENUE ANALYSIS
18.10.3 GEOGRAPHIC PRESENCE
18.10.4 PRODUCT PORTFOLIO
18.10.5 RECENT DEVELOPMENTS
18.11 EVONIK
18.11.1 COMPANY OVERVIEW
18.11.2 REVENUE ANALYSIS
18.11.3 GEOGRAPHIC PRESENCE
18.11.4 PRODUCT PORTFOLIO
18.11.5 RECENT DEVELOPMENTS
18.12 GEISTLICH HOLDING
18.12.1 COMPANY OVERVIEW
18.12.2 REVENUE ANALYSIS
18.12.3 GEOGRAPHIC PRESENCE
18.12.4 PRODUCT PORTFOLIO
18.12.5 RECENT DEVELOPMENTS
18.13 SOLVAY
18.13.1 COMPANY OVERVIEW
18.13.2 REVENUE ANALYSIS
18.13.3 GEOGRAPHIC PRESENCE
18.13.4 PRODUCT PORTFOLIO
18.13.5 RECENT DEVELOPMENTS
18.14 MATEXCEL
18.14.1 COMPANY OVERVIEW
18.14.2 REVENUE ANALYSIS
18.14.3 GEOGRAPHIC PRESENCE
18.14.4 PRODUCT PORTFOLIO
18.14.5 RECENT DEVELOPMENTS
18.15 VICTRIX INC
18.15.1 COMPANY OVERVIEW
18.15.2 REVENUE ANALYSIS
18.15.3 GEOGRAPHIC PRESENCE
18.15.4 PRODUCT PORTFOLIO
18.15.5 RECENT DEVELOPMENTS
18.16 GELITA AG
18.16.1 COMPANY OVERVIEW
18.16.2 REVENUE ANALYSIS
18.16.3 GEOGRAPHIC PRESENCE
18.16.4 PRODUCT PORTFOLIO
18.16.5 RECENT DEVELOPMENTS
18.17 STRYKER CORPORATION
18.17.1 COMPANY OVERVIEW
18.17.2 REVENUE ANALYSIS
18.17.3 GEOGRAPHIC PRESENCE
18.17.4 PRODUCT PORTFOLIO
18.17.5 RECENT DEVELOPMENTS
18.18 AVERY THEWRAPEUTICS INC
18.18.1 COMPANY OVERVIEW
18.18.2 REVENUE ANALYSIS
18.18.3 GEOGRAPHIC PRESENCE
18.18.4 PRODUCT PORTFOLIO
18.18.5 RECENT DEVELOPMENTS
18.19 OLYMPUS TERUMO BIOMATERIAL CORPORATION
18.19.1 COMPANY OVERVIEW
18.19.2 REVENUE ANALYSIS
18.19.3 GEOGRAPHIC PRESENCE
18.19.4 PRODUCT PORTFOLIO
18.19.5 RECENT DEVELOPMENTS
18.2 BERKLEYS ADVANCED BIOMATERIAL
18.20.1 COMPANY OVERVIEW
18.20.2 REVENUE ANALYSIS
18.20.3 GEOGRAPHIC PRESENCE
18.20.4 PRODUCT PORTFOLIO
18.20.5 RECENT DEVELOPMENTS
18.21 BASF SE
18.21.1 COMPANY OVERVIEW
18.21.2 REVENUE ANALYSIS
18.21.3 GEOGRAPHIC PRESENCE
18.21.4 PRODUCT PORTFOLIO
18.21.5 RECENT DEVELOPMENTS
18.22 COVESTRO AG
18.22.1 COMPANY OVERVIEW
18.22.2 REVENUE ANALYSIS
18.22.3 GEOGRAPHIC PRESENCE
18.22.4 PRODUCT PORTFOLIO
18.22.5 RECENT DEVELOPMENTS
18.23 CERAMTEC
18.23.1 COMPANY OVERVIEW
18.23.2 REVENUE ANALYSIS
18.23.3 GEOGRAPHIC PRESENCE
18.23.4 PRODUCT PORTFOLIO
18.23.5 RECENT DEVELOPMENTS
18.24 ROYALDSM
18.24.1 COMPANY OVERVIEW
18.24.2 PRODUCT PORTFOLIO
18.24.3 REVENUE ANALYSIS
18.24.4 GEOGRAPHIC PRESENCE
18.24.5 PRODUCT PORTFOLIO
18.25 CAM BIOCERAMICS B.V.
18.25.1 COMPANY OVERVIEW
18.25.2 PRODUCT PORTFOLIO
18.25.3 REVENUE ANALYSIS
18.25.4 GEOGRAPHIC PRESENCE
18.25.5 PRODUCT PORTFOLIO
*NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
19 RELATED REPORTS
20 CONCLUSION
21 QUESTIONNAIRE
22 ABOUT DATA BRIDGE MARKET RESEARCH
